FDA Inspection 963017 — ENDO USA, Inc

ENDO USA, Inc — FEI 2410861

The FDA completed an inspection of ENDO USA, Inc on January 27, 2016 in Rye, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 27, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rye, NY (United States)